Efficacy of an Abbreviated Induction Regimen of Amphotericin B Deoxycholate for Cryptococcal Meningoencephalitis: 3 Days of Therapy Is Equivalent to 14 Days
ABSTRACT Cryptococcal meningoencephalitis is an urgent global health problem. Induction regimens using 14 days of amphotericin B deoxycholate (dAmB) are considered the standard of care but may not be suitable for resource-poor settings. We investigated the efficacy of conventional and abbreviated re...
Enregistré dans:
Auteurs principaux: | Joanne Livermore, Susan J. Howard, Andrew D. Sharp, Joanne Goodwin, Lea Gregson, Timothy Felton, Julie A. Schwartz, Catherine Walker, Bill Moser, Werner Müller, Thomas S. Harrison, John R. Perfect, William W. Hope |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8a0ec99c0b4747cc8c65fa78b99ab9e1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis
par: R. Lu, et autres
Publié: (2019) -
Quality of life of HIV-negative, previously healthy individuals following cryptococcal meningoencephalitis
par: Owen Dean, et autres
Publié: (2021) -
Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice
par: Chen JH, et autres
Publié: (2011) -
CCR2 Signaling Promotes Brain Infiltration of Inflammatory Monocytes and Contributes to Neuropathology during Cryptococcal Meningoencephalitis
par: Jintao Xu, et autres
Publié: (2021) -
Choroid Plexitis and Ependymitis by Magnetic Resonance Imaging are Biomarkers of Neuronal Damage and Inflammation in HIV-negative Cryptococcal Meningoencephalitis
par: Dima A. Hammoud, et autres
Publié: (2017)